Leonardo Inks 320 Million Deal to Supply Naval Combat Systems to Kuwait Trump Indicates Iran Nuclear Deal Largely Negotiated Strait of Hormuz Reopening Eyed Investors Eye AMD Arm Marvell as Potential AI Chip Contenders Beyond Nvidia Kevin Warshs Potential Fed Overhaul A Shift in Wall Streets Plumbing SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lag Walmart Expands LTL Truck Consolidation Program to Enhance Supply Chain Efficiency EXPE Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Resilient Travel Demand BAH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress CIMP Q1 2026 Earnings EPS Beats Estimates as Mortgage REIT Maintains Stable Performance Dawson Geophysical Q2 2019 Earnings EPS Misses Estimates Amid Challenging Environment Domo Q1 2026 Earnings EPS Surges Past Estimates Stock Rises Southland Holdings SLND Surges 17 as Infrastructure Play Breaks Above Key Resistance NexPoint Residential Trust NXRT Posts Modest Uptick Amid Steady Multifamily Demand LiqTech International LIQT Gains 222 Approaches Resistance Level American Integrity Insurance Group AII Edges Higher Key Levels in Focus Indigo Acquisition Corp Unit INACU Holds Steady Near Trust Value Amid Limited Trading Activity Trust Tax Planning How to Minimize Taxes on 300000 Annual Family Trust Income Bone Biologics Corp BBLG Q1 2026 Earnings Narrower Loss Beats Estimates Shares Dip LG Display Shares Edge Higher as Display Sector Shows Resilience LPL Indian Indices Edge Higher Amid Mixed Signals Geopolitical Risks Weigh on Sentiment Jeff Bezos Proposes Zero Federal Income Tax for Some Americans Implications for Tax Policy and Economy NSA Q1 2026 Earnings EPS Beats Estimates as SelfStorage REIT Reports Strong Results BRFH Q1 2026 Earnings Narrowing Loss Beats Expectations as Cost Controls Take Effect Japanese Equities Surge as Nikkei 225 Climbs 274 at Close BLTE Q4 2025 Earnings WiderthanExpected Loss as PreRevenue Biotech Remains Focused on Clinical Development Singtel Shares Slide 64 on Weak Singapore Performance Group Reaffirms Optus Commitment